全文获取类型
| 收费全文 | 383354篇 |
| 免费 | 24498篇 |
| 国内免费 | 2807篇 |
专业分类
| 耳鼻咽喉 | 5264篇 |
| 儿科学 | 8282篇 |
| 妇产科学 | 10097篇 |
| 基础医学 | 53579篇 |
| 口腔科学 | 11832篇 |
| 临床医学 | 30368篇 |
| 内科学 | 79431篇 |
| 皮肤病学 | 8627篇 |
| 神经病学 | 27513篇 |
| 特种医学 | 14008篇 |
| 外国民族医学 | 82篇 |
| 外科学 | 61485篇 |
| 综合类 | 9971篇 |
| 现状与发展 | 1篇 |
| 一般理论 | 64篇 |
| 预防医学 | 17548篇 |
| 眼科学 | 9603篇 |
| 药学 | 31251篇 |
| 7篇 | |
| 中国医学 | 2204篇 |
| 肿瘤学 | 29442篇 |
出版年
| 2021年 | 2710篇 |
| 2019年 | 2778篇 |
| 2018年 | 4586篇 |
| 2017年 | 3492篇 |
| 2016年 | 3612篇 |
| 2015年 | 4124篇 |
| 2014年 | 5823篇 |
| 2013年 | 7513篇 |
| 2012年 | 10196篇 |
| 2011年 | 10428篇 |
| 2010年 | 6332篇 |
| 2009年 | 5951篇 |
| 2008年 | 9635篇 |
| 2007年 | 10485篇 |
| 2006年 | 10425篇 |
| 2005年 | 9505篇 |
| 2004年 | 8988篇 |
| 2003年 | 8728篇 |
| 2002年 | 8426篇 |
| 2001年 | 28308篇 |
| 2000年 | 28876篇 |
| 1999年 | 23729篇 |
| 1998年 | 5212篇 |
| 1997年 | 4300篇 |
| 1996年 | 3867篇 |
| 1995年 | 3516篇 |
| 1994年 | 3141篇 |
| 1993年 | 2871篇 |
| 1992年 | 16115篇 |
| 1991年 | 14871篇 |
| 1990年 | 14213篇 |
| 1989年 | 14008篇 |
| 1988年 | 12638篇 |
| 1987年 | 12103篇 |
| 1986年 | 11144篇 |
| 1985年 | 10368篇 |
| 1984年 | 6946篇 |
| 1983年 | 5625篇 |
| 1982年 | 2742篇 |
| 1979年 | 5504篇 |
| 1978年 | 3356篇 |
| 1977年 | 2990篇 |
| 1975年 | 2650篇 |
| 1974年 | 3083篇 |
| 1973年 | 2878篇 |
| 1972年 | 2849篇 |
| 1971年 | 2791篇 |
| 1970年 | 2526篇 |
| 1969年 | 2563篇 |
| 1968年 | 2266篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
991.
992.
Multiple intrahepatic arterio-portal fistulas are rare. The majority are isolated and occur secondary to liver trauma including iatrogenic interventions such as liver biopsy. Post–liver transplantation 18 cases have been reported, all secondary to an interventional radiological procedure. We report multiple bi-lobar arterio-portal fistulas in a liver transplant recipient recognized 1 year after transplantation. The donor died due to intracerebral bleeding following blunt head and abdominal trauma. In the present case, the etiology is not very clear. The patient was managed conservatively and to date has not required intervention. 相似文献
993.
J.C. Na J.S. Park M.-G. Yoon H.H. Lee Y.E. Yoon K.H. Huh Y.S. Kim W.K. Han 《Transplantation proceedings》2018,50(4):1018-1021
Background
Although renal function recovery of living kidney donors has been reported in a number of studies, many patients show poor recovery, and the long-term prognosis of these patients has not been well studied. In this investigation we explored the long-term prognosis of renal function in patients with chronic kidney disease (CKD) at 1 year after nephrectomy.Methods
Patients who underwent donor nephrectomy during the period from March 2006 to April 2014, with a follow-up creatinine study at 1 year postoperatively and more than 3 years of follow-up, were included in the study. Creatinine and estimated glomerular filtration rate (eGFR, using the Modification of Diet in Renal Disease formula) before and after surgery were studied. Age, sex, history of hypertension or diabetes, body mass index, blood pressure, complete blood count, preoperative routine serum chemistry, and urine study results were reviewed.Results
Among 841 patients who had donor nephrectomy, 362 were included in the study. There were 111 patients (30.6%) with eGFR <60 mL/min/1.73 m2 at 1 year postsurgery, and the median follow-up period was 62.8 months (interquartile range [IQR] 42.0–86.3 months). The maximum eGFR after 3-year follow-up was studied, and 48 patients (43.2%) never recovered eGFR to >60 mL/min/1.73 m2. Age, history of hypertension, preoperative eGFR, and eGFR at 1 year were predictive factors at univariate analysis. Multivariate analysis of these factors was studied, and age (52.5 [IQR 47–55.7] vs 47 [IQR 7–53] years, odds ratio [OR] 1.1, 95% confidence interval [CI] 1.02–1.15, P = .007), history of hypertension (16.7% vs 1.6%, OR 10.0, 95% CI 1.09–92.49, P = .042), and eGFR at 1 year (53.9 [IQR 50.3–56.0] vs 57.0 [IQR 54.2–58.4] mL/min/1.73 m2, OR 0.8, 95% CI 0.72–0.92, P = .002) remained as significant risk factors.Conclusion
Of all living donors, 15.7% had CKD after >3 years of follow-up. Close observation is warranted when donors have CKD after 1 year follow-up, as 43.2% fail to recover renal function. Patients who are older, have a history of hypertension, and have low eGFR at 1-year follow-up are especially at risk. 相似文献994.
Background
Although cancer screening tests are not mentioned under brain-dead organ donor care guidelines in Korea, we assessed the level of prostate-specific antigen (PSA), an important prostate cancer marker, and performed prostate biopsies when needed in brain-dead organ donors. We believe that insisting on a screening test for cancer diagnosis in donors' organs is important.Materials and Methods
Data were collected between January 2010 and July 2015 from Ajou University Hospital. We retrospectively analyzed the PSA levels and prostate biopsy results in 111 male brain-dead organ donors (mean age, 48.4 years).Results
The mean PSA level was 7.395 ng/mL (range, 0.062 to 61.780; reference, 0 to 4 ng/mL). Ultrasonography or computed tomographic examination did not reveal prostate cancer, and a rectal examination was not performed. After checking the PSA levels, prostate biopsies were performed in 16 patients based on the recommendations of a urologist, and 4 patients (3.6% of 111) were diagnosed with prostate cancer. All cancers involved adenocarcinomas (acinar type) histopathologically. In 2 patients, the Gleason score was 6 (3 + 3), whereas the other 2 showed a score of 7 (3 + 4). Among the patients diagnosed with prostate cancer, 1 donated his liver and corneas, and the remaining 3 could not donate.Conclusion
Well-defined cancer screening tests are needed in Korea. Additionally, when the probability of organ transplantation-induced cancer metastasis is low or a recipient is at a high risk owing to not receiving organs, the law should allow organ donation even if prostate cancer is diagnosed in the donor. 相似文献995.
Background
Single antigen bead assay (SAB) is a sensitive method for detecting HLA antibodies, but it does not specifically identify clinically relevant subsets. Recently, a new assay has been developed for detection of C3d bound to HLA antibody-antigen complex. We evaluated the C3d assay regarding its correlation with SAB in renal patients.Methods
A total of 138 serum samples from 109 sensitized patients were tested in parallel by SAB and C3d assay for detection of HLA class I antibodies. The relationship between C3d assay and SAB was analyzed for the numbers and median fluorescent intensity (MFI) values of the identified antibodies.Results
Of the 138 samples, 137 were positive on SAB; of the 137 SAB-positive samples, 76 were positive on C3d assay. A total of 3748 and 685 antibodies were identified by the SAB and the C3d assay, respectively. The maximal MFI values of the SAB in the 76 samples that were C3d assay-positive were significantly higher than those of the 61 samples that were C3d assay-negative (P < .05), with the median values of 17,057 and 6066, respectively. Only 11 (0.4%) of the 2905 antibodies with MFI < 10,000 on SAB vs 501 (59.4%) of the 843 antibodies with MFI > 10,000 on SAB were identified by C3d assay with MFI > 1000.Conclusions
The C3d assay positivity seems to be dependent on its MFI value on SAB. Further studies are needed to ascertain the clinical significance of C3d positivity by itself. 相似文献996.
997.
Uterus transplantation (UTx) has become an alternative to gestational surrogacy and adoption for women with uterine factor infertility (UFI). Brännström et al achieved the first human delivery after UTx in 2014, and to date a total of 8 babies have been born after UTx from living donors. This outcome has attracted much attention worldwide, and many countries are now preparing for UTx.There are an estimated 60,000 women of reproductive age with UFI in Japan, and these patients cannot have biological children because gestational surrogacy is forbidden in Japan. We have performed UTx research from 2009 using cynomolgus macaque, in preparation for clinical application of UTx for these patients to have a child, and we have accumulated a large amount of data. However, the UTx procedure still has many medical, ethical, and social issues that require discussion prior to clinical application. The Japan Society for Uterus Transplantation was established in 2014 for further discussion of these issues in Japan.UTx is still in the experimental stage overseas, and the safety and efficacy remain unclear, despite several clinical applications. Despite the many issues to be resolved, this organ transplantation technology will provide new hope for women with UFI, and further development of the technology is important for future reproductive and transplant medicine.In this article, we summarize the current status of UTx and the situation regarding future clinical application in Japan. 相似文献
998.
J.Y. Park M.H. Kim E.J. Bae S. Kim D.K. Kim K.W. Joo Y.S. Kim J.P. Lee Y.H. Kim C.S. Lim 《Transplantation proceedings》2018,50(4):1068-1073
Background
Comorbid conditions are important in the survival of kidney transplant recipients. The weights assigned to comorbidities to predict survival may vary based on the type of index disease and advances in the management of comorbidities. We aimed to develop a modified Charlson comorbidity index (CCI) in renal allograft recipients (mCCI-KT), thereby improving risk stratification for mortality.Methods
A total of 3765 recipients in a multicenter cohort were included to develop a comorbidity score. The weights of the comorbidities, per the CCI, were recalibrated using a Cox proportional hazards model.Results
Peripheral vascular disease, liver disease, myocardial infarction, and diabetes in the CCI were selected from the Cox proportional hazards model. Thus, the mCCI-KT included 4 comorbidities with recalibrated severity weights. Whereas the CCI did not discriminate for survival, the mCCI-KT provided significant discrimination for survival using the Kaplan-Meier method and Cox regression analysis. The mCCI-KT showed modest increases in c-statistics (0.54 vs 0.52, P = .001) and improved net mortality risk reclassification by 16.3% (95% confidence interval, 3.2–29.4; P = .015) relative to the CCI.Conclusion
The mCCI-KT stratifies the risk for mortality in renal allograft recipients better than the CCI, suggesting that it may be a preferred index for use in clinical practice. 相似文献999.
H.-K. Wang C.-Y. Chen N.-C. Lin C.-S. Liu C.-C. Loong Y.-H. Lin Y.-C. Lai H.-J. Chiou 《Transplantation proceedings》2018,50(4):1157-1159
Background
Intraoperative portal venous flow measurement provides surgeons with instant guidance for portal flow modulation during living-donor liver transplantation (LDLT). In this study, we compared the agreement of portal flow measurement obtained by 2 devices: transit time ultrasound (TTU) and conventional Doppler ultrasound (CDU).Methods
Fifty-four recipients of LDLT underwent intraoperative measurement of portal flow after completion of vascular anastomosis of the implanted partial liver graft. Both TTU and CDU were used concurrently. Agreement of TTU and CDU was assessed by intraclass correlation coefficient using a model of 2-way random effects, absolute agreement, and single measurement. A Bland-Altman plot was applied to assess the variability between the 2 devices.Results
The mean, median, and range of portal venous flow was 1456, 1418, and 117 to 2776 mL/min according to TTU; and 1564, 1566, and 119 to 3216 mL/min according to CDU. The intraclass correlation coefficient of portal venous flow between TTU and CDU was 0.68 (95% confidence interval, 0.51–0.80). The Bland-Altman plots revealed an average variation of 4.8% between TTU and CDU but with a rather wide 95% confidence interval of variation ranging from ?57.7% to 67.4%.Conclusions
Intraoperative TTU and CDU showed moderate agreement in portal flow measurement. However, a relatively wide range of variation exists between TTU and CDU, indicating that data obtained from the 2 devices may not be interchangeable. 相似文献1000.
S. González Martínez A. Molina Raya A. Becerra Massare K. Muffak Granero T. Villegas Herrera J.M. Villar del Moral Y. Fundora Suárez 《Transplantation proceedings》2018,50(2):595-597